Skip to main content

Find Clinical Trials

Home
Conditions
Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients

Clinical trial condition

Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients

Explore clinical trials studying Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients trial results

Completed

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

NCT00961896

Conditions: Abnormalities, Multiple, Basal Cell Nevus Syndrome, Bone Cysts, +19 more
Locations: Novartis Investigative Site Graz, Austria

Novartis Investigator Site Vienna, Austria

Novartis Investigative Site Zurich, Switzerland

View Trial Details